BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 20938052)

  • 1. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
    Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
    Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
    RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14.
    Feng JF; Yang WY; Wang YD; Xie G; Xu B; Dai CM; Zhang B; Li XH; Wang J; Yang YW
    Oxid Med Cell Longev; 2022; 2022():8645830. PubMed ID: 36062189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
    Gonçalves V; Matos P; Jordan P
    Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer.
    Sveen A; Bakken AC; Ågesen TH; Lind GE; Nesbakken A; Nordgård O; Brackmann S; Rognum TO; Lothe RA; Skotheim RI
    Int J Cancer; 2012 Sep; 131(6):1479-85. PubMed ID: 22173985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
    Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
    Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis.
    Thorsen K; Schepeler T; Øster B; Rasmussen MH; Vang S; Wang K; Hansen KQ; Lamy P; Pedersen JS; Eller A; Mansilla F; Laurila K; Wiuf C; Laurberg S; Dyrskjøt L; Ørntoft TF; Andersen CL
    BMC Genomics; 2011 Oct; 12():505. PubMed ID: 21999571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
    Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
    Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
    Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
    PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
    Das S; Anczuków O; Akerman M; Krainer AR
    Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells.
    Hu ZY; Wang XY; Guo WB; Xie LY; Huang YQ; Liu YP; Xiao LW; Li SN; Zhu HF; Li ZG; Kan H
    Oncotarget; 2016 Mar; 7(10):11733-43. PubMed ID: 26887056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
    Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
    PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
    de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
    Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
    Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.
    Herbst A; Jurinovic V; Krebs S; Thieme SE; Blum H; Göke B; Kolligs FT
    BMC Genomics; 2014 Jan; 15():74. PubMed ID: 24467841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
    Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing kinase SRPK1 conforms to the landscape of its SR protein substrate.
    Aubol BE; Jamros MA; McGlone ML; Adams JA
    Biochemistry; 2013 Oct; 52(43):7595-605. PubMed ID: 24074032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.
    Amin EM; Oltean S; Hua J; Gammons MV; Hamdollah-Zadeh M; Welsh GI; Cheung MK; Ni L; Kase S; Rennel ES; Symonds KE; Nowak DG; Royer-Pokora B; Saleem MA; Hagiwara M; Schumacher VA; Harper SJ; Hinton DR; Bates DO; Ladomery MR
    Cancer Cell; 2011 Dec; 20(6):768-80. PubMed ID: 22172722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2β1.
    Jamros MA; Aubol BE; Keshwani MM; Zhang Z; Stamm S; Adams JA
    J Biol Chem; 2015 Jul; 290(28):17269-81. PubMed ID: 26013829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.